Cerebrolysin is a peptide preparation consisting of low-molecular-weight peptides and free amino acids derived from purified pig brain tissue through enzymatic proteolysis. The mixture contains neurotrophic factors and neurotransmitter precursors that can cross the blood-brain barrier. Cerebrolysin has been used clinically in Europe and Asia for decades to treat stroke, traumatic brain injury, and dementia. The preparation contains active fragments similar to naturally occurring neurotrophins including BDNF and NGF. Research suggests it promotes neurogenesis, synaptogenesis, and neuroprotection through multiple mechanisms including enhancement of neuroplasticity.
| Research Status | Approved (Europe, Asia) |
|---|---|
| Half-Life | Variable (mixture) |
| Administration | IV or IM injection |
| Typical Dosage | 5-30 mL IV |
| Molecular Weight | < 10,000 Da (mixture of peptide fragments) |
| Molecular Formula | Variable mixture of peptides and amino acids |
Multiple neurotrophic factors that promote neuroplasticity, neuroprotection, and neurogenesis.
All information is presented for Research Use Only (RUO). Not medical advice.